NeuroXPF - 606236 - 03/31/2020
Recipient: NeuroXPF 3900 South Hualapai Way, Suite 128 Las Vegas, NV 89147 United States support@neuroxpf.com Issuing Office: Center for Drug Evaluation and Research | CDER United States WARNING LETTER Date: March 31, 2020 RE: …